Thyroid function was assessed at the time of initial diagnosis in 204 patients with lung cancer and compared with that of age and sex-matched patients with nonmalignant lung disease. Abnormalities in thyroid function were found in 67 patients (33%). The most prevalent abnormality was a low T3 concentration; this was not associated with other clinical or biochemical evidence of hypothyroidism, but the short-term prognosis of these patients was worse than that of matched patients with lung cancer having normal T3 concentrations. Primary hypothyroidism occurred in three patients, low T4 concentrations and free thyroxine index (FTI) with normal thyrotrophin (TSH) concentrations in four patients, and moderately raised TSH with normal thyroid hormone concentrations in six patients; nine patients had a raised FTI with or without raised T4 concentration as the sole abnormality.
Summary and conclusions
Thyroid function was assessed at the time of initial diagnosis in 204 patients with lung cancer and compared with that of age and sex-matched patients with nonmalignant lung disease. Abnormalities in thyroid function were found in 67 patients (33%). The most prevalent abnormality was a low T3 concentration; this was not associated with other clinical or biochemical evidence of hypothyroidism, but the short-term prognosis of these patients was worse than that of matched patients with lung cancer having normal T3 concentrations. Primary hypothyroidism occurred in three patients, low T4 concentrations and free thyroxine index (FTI) with normal thyrotrophin (TSH) concentrations in four patients, and moderately raised TSH with normal thyroid hormone concentrations in six patients; nine patients had a raised FTI with or without raised T4 concentration as the sole abnormality.
Overall, the pattern of thyroid hormone metabolism in lung cancer was a tendency towards reduced T3 concentrations with significantly increased T4,T3 ratios and modestly increased 3,3',5'-triiodothyronine (rT3) concentrations. The altered T4 T3 ratio was particularly noticeable in patients with anaplastic tumours of small ("oat cell") and large cell types, but was not apparently related to detectable extrathoracic metastases.
These data suggest that thyroid hormone metabolism is altered in patients with lung cancer by decreased 5'-monodeiodination of T4. The resulting low T3 concentrations and altered T4/T3 ratio may be partly responsible for the reduced ratio of androsterone to aetiocholanolone observed in lung cancer, which is known to be a poor prognostic sign.
Introduction
A relationship between thyroid function and cancer has been postulated since Beatson' successfully treated a woman with metastatic breast carcinoma by oophorectomy combined with thyroid extract. Considerable indirect evidence suggests an interaction between thyroid function and malignant disease, particularly breast carcinoma.25 The association of thyroid disease with lung cancer, however, has only occasionally been reported. Hyperthyroidism in this condition was described by de Gennes et a16 and Rassam and Anderson-(one patient is reported to have shown direct evidence of inappropriate TSH production by the tumour). We have compared thyroid function in patients with lung cancer at the time of initial diagnosis with that in ageand sex-matched patients with non-malignant lung disease in an attempt to define the presence, nature, and possible mechanism of any abnormalities. Control patienlts-Serum samples from 70 clinically euthyroid patients attending one of the chest clinics with non-malignant lung disease (mainly chronic bronchitis and tuberculosis) were taken for thyroid function studies. These patients were age-and sex-matched with the 55 lung cancer patients who were studied histologically. As with the lung cancer group, patients with thyroid disease or taking drugs known to affect thyroid hormone metabolism were excluded.
Methods

LABORATORY METHODS
Total thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3), and thyroid-stimulating hormone (TSH) were measured by double antibody radioimmunoassays in unextracted serum.911 The free thyroxine index (FTI) was calculated from the ratio total T4 thyroid hormone uptake test x 100. Thyopac 3 (Radiochemical Centre, Amersham) was used for the uptake test.
The statistical significance of differences between groups was determined by the Student's t test.
Results
Thyroid ftiction in total grouip of lunig cantcer patients-The mean serum T3 and T4 concentrations and FTI (see figure) in the patients with the lung cancer were within the reference ranges established for euthyroid hospitalised patients, which are similar to the absolute ranges for the control patients. Mean T4 and rT3 concentrations and FTI were slightly but not significantly higher than in the control patients, whereas the mean T3 concentration was significantly lower (P < 0-001 
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Conversion: SI to traditional uznits-T3: 1 nmol 1 = 0-065 ,ug 100 ml. T4: 1 nmol 1 = 0-078 yug 100 ml.
concentration as the sole abnormality-that is, the biochemical pattern of subclinical hypothyroidism-and nine patients (cases Conzversion: SI to traditionzal unzits-T3: 1 nmoll1 = 0-065 ,ugi100 ml. T4: 1 nmol/l = 0-078 ,g'100 ml. of 55 lung cancer patients who were studied histologically showed a pattern of thyroid hormone concentrations similar to that of the total lung cancer group (table III) . Patients with all the histological types of lung cancer had a higher T4 T3 ratio than did the controls, though the difference reached statistical significance only in the small-cell anaplastic group.
Relationship of thy,roid hormone concentrations to extrathoracic metastases-There was no significant difference in thyroid hormone or TSH concentrations between the 103 patients with apparently localised disease and the 101 with extrathoracic metastases.
Discussion
The results of our study indicate that in newly diagnosed patients with lung cancer the overall prevalence of previously unrecognised primary hypothyroidism is 15",, and of minor degrees of hypothyroidism (defined on the basis of raised TSH concentrations) 3",,. This is not appreciably different from the prevalence that might be expected in a group of similar age and sex composition without malignant disease, for Tunbridge et all2 reported the overall prevalence of spontaneous overt hypothyroidism in an adult population in north-east England as between 0 8 and 1 1°,, with minor degrees of hypothyroidism in 7 5",, of women and 2 8°0 , of men. Primary hypothyroidism occurred only in elderly women and is likely to be due to coincident autoimmune thyroid disease. Four patients (20 ,) showed the biochemical pattern of secondary hypothyroidism, though none had clinical evidence of hypopituitarism or metastatic disease in the hypothalamus or pituitary.
The absence of any patients with biochemical or clinical evidence of hyperthyroidism (the prevalence of which is less than 0 5",) confirms the rarity of its association with lung cancer. Increased TSH-like immunoactivity was associated not with increased thyroid activity but rather with the thyroid hormone pattern of subclinical hypothyroidism.-
We observed a marginally raised T4 concentration or FTI, or both, in about 40°of euthyroid lung cancer patients aged between 54 and 82; but a small increase in T4 concentration may occur in euthyroid elderly people and our finding may not reflect any condition needing treatment.'3 This interpretation is supported by the finding of low normal T3 concentrations in these patients (mean 1-49 nmol/l (0-097 xag/100 ml) ).
The most striking abnormality of thyroid hormone metabolism was a biochemical syndrome of low T3 concentration, normal T4 concentration and FTI, and normal or slightly raised reverse T3 concentration, which has been described in various acute and chronic illnesses (the "sick euthyroid" or "low T3" syndrome).'4'6 This has been reported in patients with disseminated malignancy, 1 though neither of the patients with carcinoma of the lung described by Bermudez and colleagues1; had a low T3 concentration. Our data suggest that the syndrome was not solely related to severity of illness as most of the patients with lung cancer were ambulant and attending a chest clinic for the first time, whereas many of the control patients had advanced chronic lung disease. Moreover, lung cancer apparently restricted to the thorax may be associated with the syndrome, as no significant differences were found between patients with and without extrathoracic metastases. While undetected metastatic disease cannot be excluded in patients thought to have disease confined to the thorax, even localised lung cancer probably exerts a powerful effect on T4 metabolism. There is, however, no evidence that such patients with low T3 concentrations are clinically hypothyroid, and our patients with lung cancer had TSH concentrations that were similar and within the normal range whether or not their T3 concentrations were subnormal. Moreover, patients with the low-T3 syndrome show a normal response to TRH. 16 The low T3 concentrations appear to be due to inhibition of the rate of extrathyroidal 5'-monodeiodination of T4 to metabolically active T3 and an increased rate of 5-deiodination of T4 to metabolically inactive reverse T3, rather than to an increased rate of T3 catabolism or selective decrease in thyroidal T3 secretion.' Analysis of the data on the patients studied histologically suggests that this pattern is more definite in the anaplastic tumour group than in the squamous-cell group. Small-cell anaplastic tumours are biochemically active since they are particularly associated with ectopic hormone production and increased corticosteroid excretion.' 19 Possibly such tumours secrete substances that influence the pathway of T4 monodeiodination either directly or via corticosteroids, as these alter the pathway of T4 metabolism in favour of reverse T3.2 Alternatively, the altered metabolic pathway may be a relatively non-specific effect of illness that is especially pronounced in patients with anaplastic tumours.
Whatever the mechanism, low T3 concentrations and an increased T4 T3 ratio may have implications for prognosis and treatment since low T3 concentrations may induce changes in the ratio of 5 n to 5x corticosteroids (androsterone 'aetiocholanolone). In anorexia nervosa, for example, the low-T3 syndrome is associated with an increased 55/5x ratio, which is reversed by administering exogenous T3.2' An increased 5( 5x ratio is a poor prognostic sign in lung cancer,2 and indeed our patients with low T3 levels had a poor short-term prognosisabout twice as many of these patients died within six months as of the matched group with normal T3 concentrations. Clearly more detailed follow-up studies of these patients, with direct measurements of thyroid hormone and relevant corticosteroid concentrations, are required to test this hypothesis.
